Page 37 - ITPS-8-1
P. 37
INNOSC Theranostics and
Pharmacological Sciences Transcriptome-based RNA sequencing
72. Tasaki S, Suzuki K, Kassai Y, et al. Multi-omics monitoring doi: 10.1007/s00204-020-02656-y
of drug response in rheumatoid arthritis in pursuit of 78. Mukherjee A, Abraham S, Singh A, Balaji S, Mukunthan KS.
molecular remission. Nat Commun. 2018;9(1):2755. From data to cure: A comprehensive exploration of multi-
doi: 10.1038/s41467-018-05044-4 omics data analysis for targeted therapies. Mol Biotechnol.
2024:1-21.
73. Ding Z, Chen W, Wu H, et al. Integrative network fusion-
based multi-omics study for biomarker identification and 79. O’Connor LM, O’Connor BA, Lim SB, Zeng J, Lo CH.
patient classification of rheumatoid arthritis. Chin Med. Integrative multi-omics and systems bioinformatics in
2023;18(1):48. translational neuroscience: A data mining perspective.
J Pharm Anal. 2023;13(8):836-850.
doi: 10.1186/s13020-023-00750-8
doi: 10.1016/j.jpha.2023.06.011
74. Xiao H, Bartoszek K, Lio P. Multi-omic analysis of signalling
factors in inflammatory comorbidities. BMC Bioinformatics. 80. O’Donnell ST, Ross RP, Stanton C. The progress of multi-
2018;19:439. omics technologies: Determining function in lactic acid
bacteria using a systems level approach. Front Microbiol.
doi: 10.1186/s12859-018-2413-x 2020;10:3084.
75. Jian C, Wei L, Wu T, et al. Comprehensive multi-omics doi: 10.3389/fmicb.2019.03084
analysis reveals the core role of glycerophospholipid
metabolism in rheumatoid arthritis development. Arthritis 81. Lorefice L, Pitzalis M, Murgia F, Fenu G, Atzori L, Cocco E.
Res Ther. 2023;25(1):246. Omics approaches to understanding the efficacy and safety
of disease-modifying treatments in multiple sclerosis. Front
doi: 10.1186/s13075-023-03208-2 Genet. 2023;14:1076421.
76. Dai X, Shen L. Advances and trends in omics technology doi: 10.3389/fgene.2023.1076421
development. Front Med (Lausanne). 2022;9:911861.
82. Grieshaber-Bouyer R, Exner T, Hackert NS, et al. Ageing
doi: 10.3389/fmed.2022.911861 and interferon gamma response drive the phenotype
of neutrophils in the inflamed joint. Ann Rheum Dis.
77. Canzler S, Schor J, Busch W, et al. Prospects and challenges
of multi-omics data integration in toxicology. Arch Toxicol. 2022;81(6):805-814.
2020;94:371-388. doi: 10.1136/annrheumdis-2021-221866
Volume 8 Issue 1 (2025) 31 doi: 10.36922/itps.4449

